Feedback / Questions
AFNT-111 - Affini-T Therap, Erasca
https://www.businesswire.com/news/home/20221107005425/en/Affini-T-Therapeutics-to-Present-Preclinical-Data-from-its-Lead-Programs-Targeting-KRAS-G12V-at-the-Society-for-Immunotherapy-of-Cancer-SITC-37th-Annual-Meeting
Nov 7, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next